Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,208
Sort by:
Vaginal Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Vaginal Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Drugs In Development, 2021, provides...
October 2021
579 pages
Top 5 Pharmaceutical Companies - Company Chartbooks
US$ 150.00
Top 5 Pharmaceutical Companies - Company Chartbooks SUMMARY All markets and industries have been affected by COVID-19 - some have benefited financially while the majority of companies in every industr...
October 2021
15 pages
Vitamin China E-News 202109
US$ 3,186.00
... , a leading producer of sodium dichromate and VK3 in China. It is likely to start equipment overhauls and ... the raw material and product to some extent. VA prices rebounded in early period of this month as a result ... into vitamin APIs, with the VB5 and VB6 projects being advanced further. Vitamins China E-News is ...
October 2021
45 pages
Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generics), By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
The global antiviral drugs market is expected to reach a value of USD 69.2 billion by 2025, based on a new report by ... ). Introduction of efficient antiviral drugs with benefits such as rapid action, increased sensitivity, and lower adverse effects is expected to serve this market as a high-impact ...
October 2021
120 pages
Basal cell carcinoma - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Basal Cell Carcinoma (Basal Cell Epithelioma) The report also ...
October 2021
70 pages
Chondrosarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Chondrosarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chondrosarcoma development. The report provides detailed ...
October 2021
60 pages
Binge-eating disorder - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Binge Disorders - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Binge Disorders development. The report provides ...
October 2021
60 pages
Herpes labialis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Herpes Labialis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Herpes Labialis development. The report provides ...
October 2021
60 pages
Hypertriglyceridemia - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Hypertriglyceridemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hypertriglyceridemia development. The report provides detailed ...
October 2021
60 pages
Liposarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Liposarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Liposarcoma development. The report provides detailed ...
October 2021
60 pages
Medulloblastoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Medulloblastoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Medulloblastoma development. The report provides detailed ...
October 2021
60 pages
Myelofibrosis - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Myelofibrosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Myelofibrosis development. The report provides detailed ...
October 2021
80 pages
Peptic Ulcer - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Peptic Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Peptic Ulcers development. The report provides ...
October 2021
60 pages
Pulmonary Embolism - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Pulmonary Embolism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pulmonary Embolism development. The report provides ...
October 2021
60 pages
Rosacea - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Rosacea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rosacea development. The report provides detailed ...
October 2021
60 pages
Narcolepsy - Pipeline Insight, 2021
US$ 1,500.00
... Narcolepsy - Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Narcolepsy. A detailed picture of the pipeline ... and Discontinued) Overview of pipeline development activities for Narcolepsy Pipeline analysis of therapeutic drugs include ...
October 2021
60 pages
Ataxia-telangiectasia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Ataxia-telangiectasia - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...
October 2021
60 pages
Beta-thalassaemia - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Beta-thalassaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+...
October 2021
60 pages
Bullous pemphigoid - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Bullous pemphigoid - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ p...
October 2021
60 pages
Carcinoid Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Carcinoid Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...
October 2021
60 pages
Gaucher’s Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Gaucher’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 14+ companies and 16+ pipeline...
October 2021
60 pages
Lyme Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Lyme Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs i...
October 2021
60 pages
Muscle Spasticity - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Muscle Spasticity – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline dr...
October 2021
60 pages
Neurofibromatosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Neurofibromatosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
October 2021
60 pages
Presbyopia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Presbyopia - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs i...
October 2021
60 pages
Primary Ciliary Dyskinesia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Primary Ciliary Dyskinesia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pi...
October 2021
60 pages
Chronic Rhinosinusitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic Rhinosinusitis - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...
October 2021
60 pages
Keloids - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Keloids - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Kel...
October 2021
60 pages
Ocular Inflammation and Pain - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Ocular Inflammation and Pain – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...
October 2021
60 pages
Hemochromatosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Hemochromatosis – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drug...
October 2021
60 pages
Immune Thrombocytopenic Purpura - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Immune Thrombocytopenic Purpura - Pipeline Insight, 2021,” report provides comprehensive insights about 18+ companies and...
October 2021
60 pages
Osteonecrosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Osteonecrosis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs...
October 2021
60 pages
Peritoneal Cancer - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 5-6 business days DelveInsight’s, “Peritoneal cancer – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+...
October 2021
60 pages
Recurrent anaplastic astrocytomas - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Recurrent anaplastic astrocytomas – Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies an...
October 2021
60 pages
TIL therapy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48-72 hours DelveInsight’s, “TIL therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 20+ pipeline dru...
October 2021
60 pages
